Tenon Medical, Inc.(TNON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TNON Tenon Medical, Inc.

Trading 01-23 09:40:31 EST

0.9793

+0.0021

+0.21%

High0.9793	Low0.9723	Vol7.05K
Open0.9723	D1 Closing0.9772	Amplitude0.72%
Mkt Cap10.88M	Tradable Cap10.10M	Total Shares11.11M
T/O6.87K	T/O Rate0.07%	Tradable Shares10.32M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TNON","market":"US","secType":"STK","nameCN":"Tenon Medical, Inc.","latestPrice":0.9793,"timestamp":1769179089739,"preClose":0.9772,"halted":0,"volume":7054,"delay":0,"changeRate":0.0021489971346704776,"floatShares":10317300,"shares":11106444,"eps":-2.7551,"marketStatus":"Trading","change":0.0021,"latestTime":"01-23 09:40:31 EST","open":0.9723,"high":0.9793,"low":0.9723,"amount":6866.12898396,"amplitude":0.007163,"askPrice":0.99,"askSize":200,"bidPrice":0.95,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":-2.7551,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769202000000},"marketStatusCode":2,"adr":0,"listingDate":1651032000000,"exchange":"NASDAQ","adjPreClose":0.9772,"preHourTrading":{"tag":"盘前","latestPrice":0.9762,"preClose":0.9772,"latestTime":"09:01 EST","volume":1870,"amount":1817.1523601,"timestamp":1769176867395,"change":-0.001,"changeRate":-0.001023,"amplitude":0.016885},"postHourTrading":{"tag":"盘后","latestPrice":0.9402,"preClose":0.9737,"latestTime":"19:41 EST","volume":1267,"amount":1193.1082,"timestamp":1769128910165,"change":-0.0335,"changeRate":-0.034405,"amplitude":0.034405},"volumeRatio":3.179258},"requestUrl":"/m/hq/s/TNON/tweets","defaultTab":"tweets","newsList":[{"id":"2590858625","title":"Tenon Medical Inc - Offers Resale of 5.4 Mln Shares by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590858625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590858625?lang=en_us&edition=fundamental","pubTime":"2025-12-10 19:04","pubTimestamp":1765364686,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG01X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2584728960","title":"Tenon Medical Chief Commercial Officer Nathaniel A. Grawey Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584728960","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584728960?lang=en_us&edition=fundamental","pubTime":"2025-11-19 09:01","pubTimestamp":1763514100,"startTime":"0","endTime":"0","summary":"Nathaniel A. Grawey, Chief Commercial Officer of Tenon Medical Inc., reported an acquisition of common shares of Tenon Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL7LCGr4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tenon Medical Chief Commercial Officer Nathaniel A. Grawey Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2583238658","title":"Tenon Medical, Inc. Receives Buy Rating from Anthony Vendetti Amid Record Revenue and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2583238658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583238658?lang=en_us&edition=fundamental","pubTime":"2025-11-15 20:45","pubTimestamp":1763210736,"startTime":"0","endTime":"0","summary":"Tenon Medical, Inc., the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Anthony Vendetti from Maxim Group rei...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/tenon-medical-inc-receives-buy-rating-from-anthony-vendetti-amid-record-revenue-and-strategic-expansion-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/tenon-medical-inc-receives-buy-rating-from-anthony-vendetti-amid-record-revenue-and-strategic-expansion-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TNON"],"gpt_icon":0},{"id":"2583668822","title":"Tenon Medical price target lowered to $2.50 from $2.75 at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2583668822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583668822?lang=en_us&edition=fundamental","pubTime":"2025-11-15 00:25","pubTimestamp":1763137516,"startTime":"0","endTime":"0","summary":"Alliance Global lowered the firm’s price target on Tenon Medical (TNON) to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm’s revise...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenon-medical-price-target-lowered-to-2-50-from-2-75-at-alliance-global-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenon-medical-price-target-lowered-to-2-50-from-2-75-at-alliance-global-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2583061575","title":"Tenon Medical Raises $2.85 Million in Unregistered PIPE Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2583061575","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583061575?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:01","pubTimestamp":1763125283,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. has announced the closing of a $2.85 million at-the-market private investment in public equity  financing. The company issued a total of 2,217,904 shares of common stock along with warrants to purchase an equal number of shares at a combined price of $1.285 per share and warrant. The warrants are exercisable at $1.16 per share and will expire three years from the date of issuance. The proceeds from the PIPE will be used for working capital, product launches, commercial expansion, clinical studies, and ongoing business operations. The securities sold in this PIPE have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. without registration or an applicable exemption.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL4Gwj49:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2583514891","title":"Tenon Medical Q3 EPS $(0.40) Misses $(0.37) Estimate, Sales $1.173M Beat $1.121M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514891","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514891?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:07","pubTimestamp":1763068050,"startTime":"0","endTime":"0","summary":"Tenon Medical (NASDAQ:TNON) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.37) by 8.11 percent. This is a 88.98 percent increase over losses of $(3.63) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48850063/tenon-medical-q3-eps-0-40-misses-0-37-estimate-sales-1-173m-beat-1-121m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tenon Medical Q3 EPS $(0.40) Misses $(0.37) Estimate, Sales $1.173M Beat $1.121M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2583511060","title":"BRIEF-Tenon Medical Q3 Net Income USD -3.339 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511060","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511060?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067947,"startTime":"0","endTime":"0","summary":"BRIEF-Tenon Medical Q3 Net Income USD -3.339 Million\n\n\nNov 13 (Reuters) - Tenon Medical Q3 revenue USD 1.173 million.\n\nQ3 operating income USD -3.392 million\nQ3 operating expenses USD 4.165 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX2829EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2583511477","title":"Tenon Medical Q3 Operating Expenses USD 4.165 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511477?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX2829EB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2582036972","title":"Tenon Medical Raises $2.85 Million in PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582036972","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582036972?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:00","pubTimestamp":1762866024,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. has announced the pricing of an at-the-market private investment in public equity  financing, raising total gross proceeds of $2.85 million from several accredited investors, including strategic industry partners and members of the company's management team. As part of the PIPE, Tenon Medical will issue 2,217,904 shares of common stock and warrants to purchase an equal number of shares at a combined offering price of $1.285 per share and warrant. The warrants have a strike price of $1.16 per share and will expire three years from the date of issuance. The proceeds will be used for working capital, product launches, commercial expansion, clinical studies, and ongoing business operations. The securities sold in the PIPE are unregistered and subject to customary resale registration rights.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL5tHNQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2580786215","title":"Tenon Medical Inc. to Release Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2580786215","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580786215?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:31","pubTimestamp":1762176671,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. will release its third quarter 2025 financial results on Thursday, November 13, 2025. Results will be available after market close. A conference call to discuss the results will be held the same day at 4:30 p.m. Eastern Time. The webcast can be accessed at TNON Conference Call. Covering analysts will attend the call.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2Xv4v2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2577805315","title":"Strategic Acquisitions and Product Innovations Drive Buy Rating for Tenon Medical, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2577805315","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577805315?lang=en_us&edition=fundamental","pubTime":"2025-10-23 03:15","pubTimestamp":1761160511,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Tenon Medical, Inc., with a price target of $3.00. Ant...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-acquisitions-and-product-innovations-drive-buy-rating-for-tenon-medical-inc-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-acquisitions-and-product-innovations-drive-buy-rating-for-tenon-medical-inc-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TNON"],"gpt_icon":0},{"id":"2577087886","title":"Tenon Medical Wins FDA Clearance for SImmetry+ SI Joint Fusion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2577087886","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577087886?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:31","pubTimestamp":1761049863,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. has announced it has received FDA 510 clearance for its SImmetry+ SI Joint Fusion System. This regulatory approval expands Tenon's portfolio of minimally invasive technologies for treating sacroiliac  joint conditions, adding to its existing Catamaran SI Joint Fusion System. The SImmetry+ system features new 3D printed titanium implants, a robust joint decorticator, and a simple bone graft delivery system, providing advanced options for physicians. The company is initiating an alpha launch of SImmetry+ with a select group of physician users to gather initial feedback in preparation for a broader market rollout. The clearance further strengthens Tenon's position in the growing SI joint fusion market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL1p83tT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2576756337","title":"Tenon Medical Inc. Issues 866,642 Restricted Stock Units to Directors and Officers","url":"https://stock-news.laohu8.com/highlight/detail?id=2576756337","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576756337?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:46","pubTimestamp":1760647596,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. issued a total of 866,642 restricted stock units  to its directors and officers under the 2022 Equity Incentive Plan. The RSUs will vest in two installments: 50% on January 1, 2026, and 50% on July 31, 2026. The price of the transaction was not disclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL83SlXM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2569746807","title":"Tenon Medical Inc. Concluded Annual Meeting of Stockholders Virtually","url":"https://stock-news.laohu8.com/highlight/detail?id=2569746807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569746807?lang=en_us&edition=fundamental","pubTime":"2025-09-24 04:31","pubTimestamp":1758659477,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. held its 2025 Annual Meeting of Stockholders virtually on September 18, 2025. During the meeting, stockholders voted on the election of seven nominees to the Board of Directors. All nominees, including Richard Ferrari, Steven Foster, Richard Ginn, and Stephen Hochschuler, MD, were successfully elected. Additionally, stockholders approved a proposal concerning the exercisability of warrants issued in a transaction on March 11, 2025. The proposal involved Series C-1 and C-2 Warrants to purchase shares of common stock, and it was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDLmyHr6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2564374218","title":"Tenon Medical Inc. Announces Promising 12-Month Results from Catamaran Mainsail Study, Highlighting Significant Pain Reduction and High Fusion Rates in SI Joint Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374218?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:30","pubTimestamp":1756989026,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. Announces Promising 12-Month Results from Catamaran Mainsail Study, Highlighting Significant Pain Reduction and High Fusion Rates in SI Joint Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire  on September 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL1b0wZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2560992081","title":"Tenon Medical Inc. Launches Catamaran® SE SI Joint Fusion System to Meet Growing Market Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2560992081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560992081?lang=en_us&edition=fundamental","pubTime":"2025-08-19 20:31","pubTimestamp":1755606676,"startTime":"0","endTime":"0","summary":"Tenon Medical, Inc. has announced the full commercial market launch of its new Catamaran SE SI Joint Fusion System. This expansion marks a significant milestone for the company as it introduces a new SI Joint Fixation Device with a reduced profile, offering physicians a smaller implant option for sacroiliac joint fusion procedures. The Catamaran SE device aims to provide immediate SI joint stabilization and is designed for a minimally invasive surgical approach. This launch comes after successful performance validation during the alpha phase and aligns with Tenon's strategy to strengthen its position in the SI joint market. The company is prepared to meet growing demand with expanded inventories and field support, following the recent acquisition of SiVantage.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL2H4PB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TNON"],"gpt_icon":0},{"id":"2560000139","title":"Tenon Medical Inc. Releases Transcript of Second Quarter 2025 Financial Results and Corporate Update Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2560000139","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560000139?lang=en_us&edition=fundamental","pubTime":"2025-08-19 06:56","pubTimestamp":1755557768,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. recently held its Second Quarter 2025 Financial Results and Corporate Update Conference Call, featuring insights from key company executives including CEO and President, Steven Foster, and CFO, Kevin Williamson. The call, attended by participants from Alliance Global Partners and Maxim Group, LLC, focused on numerous strategic initiatives undertaken by the company. A significant highlight was the strategic acquisition of SiVantage, which Steven Foster described as a \"pivotal step forward\" for the company, with integration expected within the next 60-90 days. The acquisition is part of Tenon's broader strategy to diversify its product offerings and promote solutions for Sacro-Pelvic disorders, as evidenced by the launch of Catamaran SE and ongoing clinical validations. Financially, Tenon reported a 29% reduction in operating expenses year-over-year, and ended the quarter with $7.8 million in cash and no debt. This financial position, according to Foster, provides \"the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDLb13bkP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"1177760629","title":"Tenon Medical Q2 2025 Earnings Call Summary and Q&A Highlights: Strategic Acquisition and Product Launches to Drive Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1177760629","media":"Earnings Call","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177760629?lang=en_us&edition=fundamental","pubTime":"2025-08-14 05:27","pubTimestamp":1755120422,"startTime":"0","endTime":"0","summary":"[Management View]Tenon Medical reported $564,000 in revenue for fiscal Q2 2025, down from $901,000 in fiscal Q2 2024. The gross margin decreased to 43% from 52% YoY. Operating expenses were reduced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON"],"gpt_icon":0},{"id":"2559890959","title":"Tenon Medical Inc. Files Initial Beneficial Ownership Statement, Naming Nathaniel A. Grawey as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2559890959","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559890959?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:08","pubTimestamp":1755115699,"startTime":"0","endTime":"0","summary":"Tenon Medical Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing mentions Nathaniel A. Grawey as the beneficial owner, who serves as the Chief Commercial Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL6zY6JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON","BK4082"],"gpt_icon":0},{"id":"2559144989","title":"Tenon Medical Q2 EPS $(0.36) Beats $(0.47) Estimate, Sales $564.000K Miss $909.500K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559144989","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559144989?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:07","pubTimestamp":1755115622,"startTime":"0","endTime":"0","summary":"Tenon Medical (NASDAQ:TNON) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.47) by 23.4 percent. This is a 95.59 percent increase over losses of $(8.16) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47105867/tenon-medical-q2-eps-0-36-beats-0-47-estimate-sales-564-000k-miss-909-500k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tenon Medical Q2 EPS $(0.36) Beats $(0.47) Estimate, Sales $564.000K Miss $909.500K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNON"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenonmed.com","stockEarnings":[{"period":"1week","weight":0.0209},{"period":"1month","weight":-0.0814},{"period":"3month","weight":-0.2148},{"period":"6month","weight":-0.0814},{"period":"1year","weight":-0.462},{"period":"ytd","weight":0.0233}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.031385},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.09043},{"month":3,"riseRate":0.333333,"avgChangeRate":0.061924},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.203434},{"month":5,"riseRate":0,"avgChangeRate":-0.340552},{"month":6,"riseRate":0,"avgChangeRate":-0.323674},{"month":7,"riseRate":0.5,"avgChangeRate":0.010197},{"month":8,"riseRate":0.25,"avgChangeRate":-0.013997},{"month":9,"riseRate":0.25,"avgChangeRate":-0.192603},{"month":10,"riseRate":0.5,"avgChangeRate":0.049753},{"month":11,"riseRate":0.5,"avgChangeRate":-0.000687},{"month":12,"riseRate":0,"avgChangeRate":-0.174881}],"exchange":"NASDAQ","name":"Tenon Medical, Inc.","nameEN":"Tenon Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenon Medical, Inc.(TNON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tenon Medical, Inc.(TNON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tenon Medical, Inc.,TNON,Tenon Medical, Inc.股票,Tenon Medical, Inc.股票老虎,Tenon Medical, Inc.股票老虎国际,Tenon Medical, Inc.行情,Tenon Medical, Inc.股票行情,Tenon Medical, Inc.股价,Tenon Medical, Inc.股市,Tenon Medical, Inc.股票价格,Tenon Medical, Inc.股票交易,Tenon Medical, Inc.股票购买,Tenon Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenon Medical, Inc.(TNON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tenon Medical, Inc.(TNON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}